3 months ago
PMN
AnalystsKeay NakaeKeay Nakae's Stock Forecasts
AnalystsKeay Nakae
Analyst Ranking
Top 5%
#236 out of 5549 analysts
Average Return
+15.33%
Win Rate
38%120 out of 318
Risk vs Reward
Poor
Good
Keay Nakae's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Ocugen IncOCGN | +5,554.71% | $0.22 | $12.61 | 2020-06-03 - 2021-02-09 | Strong Buy |
Arrowhead Pharmaceuticals IncARWR | +417.28% | $15.28 | $79.04 | 2025-05-13 - 2026-05-12 | Strong Buy |
Arrowhead Pharmaceuticals IncARWR | +413.25% | $17.21 | $88.33 | 2025-08-11 - 2026-08-10 | Strong Buy |
Avidity Biosciences IncRNAM | +347.81% | $9.35 | $41.87 | 2023-08-09 - 2024-08-08 | Strong Buy |
Dyne Therapeutics IncDYN | +253.51% | $11.55 | $40.83 | 2023-08-04 - 2024-08-02 | Strong Buy |
Keay Nakae Analyst Color
Get additional color on Keay Nakae's coverage of popular stocks
3 months ago
ARWR
8 months ago
SABS
8 months ago
ALUR
9 months ago
KRRO
a year ago
MNPR
a year ago
RNAM
2 years ago
ABUS
2 years ago
ABUS
2 years ago
RNAM
2 years ago
RNAM
2 years ago
SLN
2 years ago
RNAM
2 years ago
DYN
3 years ago
COYA
3 years ago
SLN
3 years ago
PRQR
3 years ago
DYN
3 years ago
RNAM
3 years ago
COYA
3 years ago
SYBX
3 years ago
GANX
4 years ago
DYN
4 years ago
ALNY
4 years ago
BTTX
Keay Nakae's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Orchestra Biomed Holdings IncOBIO | 15 | Strong Buy | $20.00 | +228.41% | Maintains | 7 days ago |
Arrowhead Pharmaceuticals IncARWR | 23 | Strong Buy | $115.00 | +90.11% | Maintains | 15 days ago |
Rocket Pharmaceuticals IncRCKT | 3 | Strong Buy | $11.00 | +333.07% | Maintains | 23 days ago |
Proqr Therapeutics NvPRQR | 16 | Strong Buy | $3.00 | +108.33% | Maintains | a month ago |
Dyne Therapeutics IncDYN | 17 | Strong Buy | $38.00 | +123.00% | Maintains | a month ago |
Camp4 Therapeutics CorpCAMP | 2 | Strong Buy | $6.00 | +53.85% | Maintains | a month ago |
Prime Medicine IncPRME | 2 | Strong Buy | $7.00 | +33.59% | Maintains | a month ago |
Vyome Holdings IncHIND | 1 | Strong Buy | $3.50 | +100.00% | Initiates Coverage On | 2 months ago |
Coya Therapeutics IncCOYA | 26 | Strong Buy | $14.00 | +251.76% | Maintains | 3 months ago |
Stoke Therapeutics IncSTOK | 3 | Strong Buy | $35.00 | +32.83% | Maintains | 3 months ago |
Alnylam Pharmaceuticals IncALNY | 15 | Strong Buy | $425.00 | +144.25% | Maintains | 3 months ago |
Promis Neurosciences IncPMN | 2 | Strong Buy | $33.00 | +197.83% | Maintains | 3 months ago |
Metagenomi Therapeutics IncMGX | 1 | Strong Buy | $5.00 | +502.41% | Maintains | 4 months ago |
Ibio IncIBIO | 9 | Strong Buy | $5.00 | +514.25% | Maintains | 4 months ago |
Sab Biotherapeutics IncSABS | 20 | Strong Buy | $16.00 | +395.36% | Maintains | 4 months ago |
Alto Neuroscience IncANRO | 4 | Strong Buy | $30.00 | +27.82% | Maintains | 6 months ago |
Monopar TherapeuticsMNPR | 8 | Strong Buy | $100.00 | +39.06% | Maintains | 7 months ago |
Allurion Technologies IncALUR | 8 | Strong Buy | $45.00 | +11,588.31% | Upgrades | 8 months ago |
Korro Bio IncKRRO | 5 | Strong Buy | $15.00 | +5.63% | Upgrades | 9 months ago |
Reviva Pharmaceuticals Holdings IncRVPH | 1 | Strong Buy | $40.00 | +12,021.21% | Maintains | 10 months ago |
Arbutus Biopharma CorpABUS | 13 | Strong Buy | $5.00 | +16.82% | Maintains | a year ago |
Avidity Biosciences IncRNAM | 21 | Hold | $72.00 | +388.14% | Maintains | a year ago |
Silence Therapeutics PLCSLN | 13 | Strong Buy | $35.00 | N/A | Maintains | a year ago |
Seres Therapeutics IncMCRB | 10 | Hold | $6.00 | N/A | Downgrades | a year ago |
Sonnet Biotherapeutics Holdings IncSONN | 13 | Strong Buy | $20.00 | N/A | Maintains | 2 years ago |
Gain Therapeutics IncGANX | 6 | Strong Buy | $6.00 | N/A | Maintains | 2 years ago |
Femasys IncFEMY | 10 | Strong Buy | $160.00 | N/A | Maintains | 2 years ago |
Omega Therapeutics IncOMGAQ | 6 | Strong Buy | $6.00 | N/A | Maintains | 2 years ago |
Notable Labs LtdNTBLQ | 2 | Strong Buy | $5.00 | N/A | Maintains | 2 years ago |
Synlogic IncSYBX | 5 | Hold | N/A | N/A | Downgrades | 3 years ago |
Better Therapeutics IncBTTX | 6 | Strong Buy | $9.00 | N/A | Reiterates | 3 years ago |
Mesoblast LtdMESO | 7 | Strong Sell | $6.00 | N/A | Maintains | 3 years ago |
Pear Therapeutics IncPEARQ | 5 | Hold | $8.00 | N/A | Downgrades | 4 years ago |
Evelo Biosciences IncEVLO | 4 | Hold | $50.00 | N/A | Downgrades | 4 years ago |
Tessera Defense & Homeland Security IncHLSQ | 4 | Strong Buy | $3,800.00 | N/A | Maintains | 4 years ago |
Emergent Biosolutions IncEBS | 8 | Strong Buy | $55.00 | N/A | Maintains | 4 years ago |
Axcella Health IncAXLA | 4 | Strong Buy | $125.00 | N/A | Maintains | 4 years ago |
Neubase Therapeutics IncNBSE | 5 | Hold | N/A | N/A | Downgrades | 4 years ago |
Exicure IncXCUR | 5 | Hold | $10.00 | N/A | Maintains | 4 years ago |
4d Pharma PLCLBPS | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Kaleido Biosciences IncKLDO | 3 | Hold | $1.70 | N/A | Downgrades | 5 years ago |
Dicerna Pharmaceuticals IncDRNA | 3 | Hold | $38.25 | N/A | Downgrades | 5 years ago |
Forte Biosciences IncFBRX | 2 | Hold | $87.50 | N/A | Upgrades | 5 years ago |
Ocugen IncOCGN | 2 | Hold | $13.00 | N/A | Downgrades | 6 years ago |
Insight Molecular Diagnostics IncIMDX | 2 | Hold | $40.00 | N/A | Downgrades | 6 years ago |
Lisata Therapeutics IncLSTA | 1 | Strong Buy | $7.00 | N/A | Maintains | 9 years ago |
Carecloud IncCCLD | 1 | Strong Buy | $2.75 | N/A | Maintains | 9 years ago |
Biocept IncBIOCQ | 1 | Strong Buy | $22,500.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.